Transforming Growth Factor-β1 Induces Apoptosis through Fas Ligand-independent Activation of the Fas Death Pathway in Human Gastric SNU-620 Carcinoma Cells

Molecular Biology of the Cell

Volumn 15, Issue 2, 2004, Pages 420-434

  Kim, Sang Gyun ^a,b   Jong, Hyun Soon ^a   Kim, Tae You ^a   Lee, Jung Weon ^a   Kim, Noe Kyeong ^a   Hong, Seung Hwan ^b   Bang, Yung Jue ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CASPASE 8 INHIBITOR; CASPASE 9; CYTOCHROME C; DEATH RECEPTOR 5; FAS ANTIBODY; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; NEUTRALIZING ANTIBODY; PROTEIN BID; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STOMACH CARCINOMA;

ANTIGENS, CD95; APOPTOSIS; ARABIDOPSIS PROTEINS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CARCINOMA; CARRIER PROTEINS; CASPASES; CYTOCHROMES C; DNA-BINDING PROTEINS; ENZYME INHIBITORS; FATTY ACID DESATURASES; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; MITOCHONDRIA; SMAD3 PROTEIN; STOMACH NEOPLASMS; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

MAMMALIA;

EID: 0742270652     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E03-04-0201     Document Type: Article

References (60)

1. Adams, J.M., and Cory, S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322-1326.
2. Attisano, L., and Wrana, J.L. (2000). Smads as transcriptional co-modulators. Curr. Opin. Cell Biol. 12, 235-243.
3. Boldin, M.P., Goncharov, T.M., Goltsev, Y.V., and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85, 803-815.
4. Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, J.H., and Wallach, D. (1995). A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
5. Chan, F.K., Chun, H.J., Zheng, L., Siegel, R.M., Bui, K.L., and Lenardo, M.J. (2000). A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351-2354.
6. Chaouchi, N., Arvanitakis, L., Auffredou, M.T., Blanchard, D.A., Vazquez, A., and Sharma, S. (1995). Characterization of transforming growth factor-β1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene 11, 1615-1622.
7. Chen, R.H., and Chang, T.Y. (1997). Involvement of caspase family proteases in transforming growth factor-β-induced apoptosis. Cell Growth Differ. 8, 821-827.
8. Chinnaiyan, A.M., O'Rourke, K., Tewari, M., and Dixit, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512.
9. Dai, J.L., Bansal, R.K., and Kern, S.E. (1999). G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc 4, phenotypes reversed by a tumorigenic mutation. Proc. Natl. Acad. Sci. USA 96, 1427-1432.
10. de Caestecker, M.P., Piek, E., and Roberts, A.B. (2000). Role of transforming growth factor-β signaling in cancer. J. Natl. Cancer Inst. 92, 1388-1402.
11. Derynck, R., and Feng, X.H. (1997). TGF-β receptor signaling. Biochim. Biophys. Acta 1333, F105-F150.
12. Derynck, R., Zhang, Y., and Feng, X.H. (1998). Smads: transcriptional activators of TGF-β responses. Cell 95, 737-740.
13. Earnshaw, W.C., Martins, L.M., and Kaufmann, S.H. (1999). Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68, 383-424.
14. Edlund, S., Bu, S., Schuster, N., Aspenstrom, P., Heuchel, R., Heldin, N.E., Ten Dijke, P., Heldin, C.H., and Landstrom, M. (2003). Transforming growth factor-β1 (TGF-β)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-β-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol. Biol. Cell 14, 529-544.
15. Faubion, W.A., Guicciardi, M.E., Miyoshi, H., Bronk, S.F., Roberts, P.J., Svingen, P.A., Kaufmann, S.H., and Gores, G.J. (1999). Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J. Clin. Investig. 103, 137-145.
16. Fujii, M., Takeda, K., Imamura, T., Aoki, H., Sampath, T.K., Enomoto, S., Kawabata, M., Kato, M., Ichijo, H., and Miyazono, K. (1999). Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell 10, 3801-3813.
17. Gold, L.I. (1999). The role for transforming growth factor-β (TGF-β) in human cancer. Crit. Rev. Oncog. 10, 303-360.
18. Graham, A., Koentges, G., and Lumsden, A. (1996). Neural crest apoptosis and the establishment of craniofacial pattern: an honorable death. Mol. Cell Neurosci. 8, 76-83.
19. Green, D.R., and Reed, J.C. (1998). Mitochondria and apoptosis. Science 281, 1309-1312.
20. Hayashi, H., et al. (1997). The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell 89, 1165-1173.
21. Heldin, C.H., Miyazono, K., and ten Dijke, P. (1997). TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
22. Hengartner, M.O. (2000). The biochemistry of apoptosis. Nature 407, 770-776.
23. Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J., Kawabata, M., and Miyazono, K. (1997). Smad6 inhibits signaling by the TGF-β superfamily. Nature 389, 622-626.
24. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y., and Nagata, S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
25. Kim, B.C., Mamura, M., Choi, K.S., Calabretta, B., and Kim, S.J. (2002). Transforming growth factor β1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells. Mol. Cell. Biol. 22, 1369-1378.
26. Kim, S.G., Kim, S.N., Jong, H.S., Kim, N.K., Hong, S.H., Kim, S.J., and Bang, Y.J. (2001). Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-β1-induced apoptosis in human gastric cancer cells. Oncogene 20, 1254-1265.
27. Lallemand, F., Mazars, A., Prunier, C., Bertrand, F., Kornprost, M., Gallea, S., Roman-Roman, S., Cherqui, G., and Atfi, A. (2001). Smad7 inhibits the survival nuclear factor kappaB and potentiates apoptosis in epithelial cells. Oncogene 20, 879-884.
28. Landstrom, M., Heldin, N.E., Bu, S., Hermansson, A., Itoh, S., ten Dijke, P., and Heldin, C.H. (2000). Smad7 mediates apoptosis induced by transforming growth factor-β in prostatic carcinoma cells. Curr. Biol. 10, 535-538.
29. Li, H., Zhu, H., Xu, C.J., and Yuan, J. (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501.
30. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S., and Wang, X. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
31. Massagué, J., and Chen, Y.G. (2000). Controlling TGF-β signaling. Genes Dev. 14, 627-644.
32. Massagué, J., and Wotton, D. (2000). Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 19, 1745-1754.
33. Micheau, O., Solary, E., Hammann, A., and Dimanche-Boitrel, M.T. (1999). Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J. Biol. Chem. 274, 7987-7992.
34. Moustakas, A., Pardali, K., Gaal, A., and Heldin, C.H. (2002). Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunol. Lett. 82, 85-91.
35. Nakao, A., et al. (1997). Identification of Smad7, a TGF-β -inducible antagonist of TGF-β signaling. Nature 389, 631-635.
36. Nguyen, A.V., and Pollard, J.W. (2000). Transforming growth factor-β3 induces cell death during the first stage of mammary gland involution. Development 127, 3107-3118.
37. Oberhammer, F.A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A.F., Bursch, W., and Schulte-Hermann, R. (1992). Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-β1. Proc. Natl. Acad. Sci. USA 89, 5408-5412.
38. Papoff, G., Hausler, P., Eramo, A., Pagano, M.G., Di Leve, G., Signore, A., and Ruberti, G. (1999). Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor. J. Biol. Chem. 274, 38241-38250.
39. Park, J.G., et al. (1997). Establishment and characterization of human gastric carcinoma cell lines. Int. J. Cancer 70, 443-449.
40. Patil, S., Wildey, G.M., Brown, T.L., Choy, L., Derynck, R., and Howe, P.H. (2000). Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-β-induced growth inhibition and apoptosis. J. Biol. Chem. 275, 38363-38370.
41. Pardali, K., Kurisaki, A., Moren, A., ten Dijke, P., Kardassis, D., and Moustakas, A. (2000). Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-β. J. Biol. Chem. 275, 29244-29256.
42. Perlman, R., Schiemann, W.P., Brooks, M.W., Lodish, H.F., and Weinberg, R.A. (2001). TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat. Cell Biol. 3, 708-714.
43. Rehemtulla, A., Hamilton, C.A., Chinnaiyan, A.M., and Dixit, V.M. (1997). Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J. Biol. Chem. 272, 25783-25786.
44. Roberts, A.B., and Sporn, M.B. (1990). The transforming growth factor-βs. In: Peptide Growth Factors and Their Receptors, part I. ed. M.B. Sporn and A.B. Roberts, Heidelberg, Germany: Springer, 419-472
45. Saltzman, A., Munro, R., Searfoss, G., Franks, C., Jaye, M., and Ivashchenko, Y. (1998). Transforming growth factor-β-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL down-regulation. Exp. Cell. Res. 242, 244-254.
46. Salvesen, G.S., and Dixit, V.M. (1997). Caspases: intracellular signaling by proteolysis. Cell 91, 443-446.
47. Schiffer, M., Bitzer, M., Roberts, I.S., Kopp, J.B., ten Dijke, P., Mundel, P., and Bottinger, E.P. (2001). Apoptosis in podocytes induced by TGF-β and Smad7. J. Clin. Investig. 108, 807-816.
48. Schrantz, N., Bourgeade, M.F., Mouhamad, S., Leca, G., Sharma, S., and Vazquez, A. (2001). p38-mediated regulation of an Fas-associated death domain protein-independent pathway leading to caspase-8 activation during TGF-β-induced apoptosis in human Burkitt lymphoma B cells BL41. Mol. Biol. Cell 12, 3139-3151.
49. Shima, Y., Nakao, K., Nakashima, T., Kawakami, A., Nakata, K., Hamasaki, K., Kato, Y., Eguchi, K., and Ishii, N. (1999). Activation of caspase-8 in transforming growth factor-β-induced apoptosis of human hepatoma cells. Hepatology 30, 1215-1222.
50. Siegel, R.M., Frederiksen, J.K., Zacharias, D.A., Chan, F.K., Johnson, M., Lynch, D., Tsien, R.Y., and Lenardo, M.J. (2000). Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288, 2354-2357.
51. Suda, T., Takahashi, T., Golstein, P., and Nagata, S. (1993). Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169-1178.
52. Tang, D., Lahti, J.M., Grenet, J., and Kidd, V.J. (1999). Cycloheximide-induced T-cell death is mediated by a Fas-associated death domain-dependent mechanism. J. Biol. Chem. 274, 7245-7252.
53. Thornberry, N.A., and Lazebnik, Y. (1998). Caspases: enemies within. Science 281, 1312-1316.
54. Trauth, B.C., Klas, C., Peters, A.M., Matzku, S., Moller, P., Falk, W., Debatin, K.M., and Krammer, P.H. (1989). Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305.
55. Wallach, D., Varfolomeev, E.E., Malinin, N.L., Goltsev, Y.V., Kovalenko, A.V., and Boldin, M.P. (1999). Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17, 331-367.
56. Yamamura, Y., Hua, X., Bergelson, S., and Lodish, H.F. (2000). Critical role of Smads and AP-1 complex in transforming growth factor-β-dependent apoptosis. J. Biol. Chem. 275, 36295-36302.
57. Yanagisawa, K., Osada, H., Masuda, A., Kondo, M., Saito, T., Yatabe, Y., Takagi, K., and Takahashi, T. (1998). Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-β in human normal lung epithelial cells. Oncogene 17, 1743-1747.
58. Yin, X.M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K.A., and Korsmeyer, S.J. (1999). Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400, 886-891.
59. Yonehara, S., Ishii, A., and Yonehara, M. (1989). A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.
60. Zou, H., Choe, K.M., Lu, Y., Massagué, J., and Niswander, L. (1997). BMP signaling and vertebrate limb development. Cold Spring Harbor Symp. Quant. Biol. 62, 269-272.